| Study Period | 2020 - 2030 |
| Market Size (2025) | USD 0.63 Billion |
| Market Size (2030) | USD 1.25 Billion |
| CAGR (2025 - 2030) | 14.75 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Single-Use Pump Market Analysis
The Single-Use Pump Market size is estimated at USD 0.63 billion in 2025, and is expected to reach USD 1.25 billion by 2030, at a CAGR of 14.75% during the forecast period (2025-2030).
Single-use pumps play a critical role in biopharmaceutical applications. Their expanding use in bioprocessing operations and continuous pump design and functionality advancements are anticipated to fuel market growth.
The notable rise in the burden of chronic diseases has resulted in increased adoption of single-use technologies, including single-use pumps, during biopharmaceutical production, thereby fueling industry growth. For instance, the American Cancer Society estimated that new cancer cases increased from 1.9 million in 2023 to 2.0 million in 2024. In 2023, the most diagnosed cancers included breast, lung, and hematological malignancies.
This projected increase in cancer cases is expected to drive the demand for innovative biopharmaceuticals. This trend is anticipated to fuel the adoption of single-use technologies, including pumps, to facilitate the transfer of various fluids, including cell culture media, buffers, and reagents, between different stages of the production process, thereby supporting industry growth.
In addition, the evolving application of single-use pumps in the biopharmaceutical sector and bioprocessing has opened new avenues for market players to develop advanced single-use pumps. For instance, the study published in Frontiers in Mechanical Engineering in July 2023 underscored the significance of peristaltic single-use pumps in biopharmaceutical applications by demonstrating their ability to facilitate fluid transfer without contamination.
This advancement enhanced operational efficiency and compliance with stringent industry health standards. Implementing single-use pumps streamlined processes while ensuring the integrity of sensitive biological materials, marking a pivotal development in biopharmaceutical manufacturing.
Furthermore, the presence of several manufacturers in the market and various strategic initiatives undertaken by them to launch innovative single-use pump systems are likely to expand product availability in the market, thereby supporting industry growth. For instance, in November 2023, PSG Biotech, a provider of pump, flow-sensor, and flow-measurement technologies for life science and biopharmaceutical applications, launched the Quattroflow QB2-Standard (QB2-SD) Single-Use Precision pump.
This introduction marked the expansion of the Quattroflow pump family with its first QB Series pump. The QB2-SD, the most miniature model in the series, is designed as a lightweight and compact rotary pump suitable for precisely transferring delicate biologics.
Therefore, the above-mentioned factors, including the notable burden of chronic diseases and technological advancements in pump design and functions, are expected to foster market growth over the forecast period. Meanwhile, the high costs associated with devices and the restrained adoption of single-use technologies in downstream processes are anticipated to impede market growth throughout the study period.
Single-Use Pump Market Trends
Peristaltic Pump Segment is Expected to Hold Largest Market Share of the Single-Use Pump Market
The peristaltic pumps segment is projected to hold the largest share and will likely maintain its dominance over the forecast period. Peristaltic pumps are positive displacement devices that move fluids through flexible tubing by creating a series of controlled contractions and relaxations.
They are widely used in pharmaceutical and biopharmaceutical industries for their ability to handle viscous, shear-sensitive, or abrasive fluids without contamination. Factors including the growing use of peristaltic pumps in the biopharmaceutical sector, growing R&D efforts by biopharmaceutical companies, technological advancements, and growing strategic initiatives to launch novel peristaltic pumps in the market are expected to boost the segment expansion over the study period.
The notable technological advancements in peristaltic pump systems and their rising applications in the pharmaceutical industry are projected to boost the segment's expansion over the study period. For instance, the study published in Science Robotics in June 2023 highlighted the significant advancements in developing compact dielectric elastomer actuator-based peristaltic pumps, demonstrating remarkable efficiency and versatility.
These pumps achieved notable performance metrics, including a maximum blocked pressure of 12.5 kilopascals and a flow rate of 39 milliliters per minute. The findings indicated a growing applicability of such pumps in the pharmaceutical industry, particularly for processes requiring precise fluid control and adaptability. This innovation positions peristaltic pumps as essential components in the evolving landscape of fluid-driven robotic systems within pharmaceutical manufacturing and therapeutic applications. Such advancements in performance and technology are projected to bolster segment uptake over the coming years.
Moreover, growing collaborative efforts to design and launch advanced peristaltic pumps for biopharmaceutical applications are expected to accelerate segment expansion over the coming years. For instance, in June 2024, Cole-Parmer, a subsidiary of Antylia Scientific, reintroduced peristaltic pumps to enhance its premier line of fluid handling solutions. In a strategic collaboration with UK-based manufacturer Watson-Marlow, the company offered innovative peristaltic pumps optimized for various laboratory, pharmaceutical, and bioprocess applications.
Similarly, strategic agreements to expand the commercial availability of peristaltic pumps are further anticipated to create new business avenues for industry growth. For instance, in June 2023, Duoning Biotechnology Co., Ltd., through Shanghai Duoning Yuexi Biological Technology Co., Ltd., signed an agreement to acquire Changzhou PreFluid Technology Co., Ltd., a Chinese manufacturer of peristaltic pumps. PreFluid's peristaltic pumps serve the medical, pharmaceutical, chemical, and environmental sectors globally. Hence, such strategic initiatives undertaken by the market participants are projected to accelerate segment expansion over the coming years.
Thus, the factors mentioned above are projected to bolster segment growth over the study period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold Significant Market Share Over the Forecast Period
The North American region is anticipated to dominate the single-use pump market during the forecast period. Such anticipated dominance can be attributed to factors such as the increasing prevalence of chronic diseases, the rising demand for technologically advanced bioprocessing solutions, and strategic initiatives by industry participants to develop and launch innovative single-use pumps tailored to the North American market.
The substantial burden of chronic diseases such as cancer and other life-threatening diseases in North America has fueled drug development activities across biopharmaceutical industries and CROs. This is anticipated to bolster the demand for single-use pumps in these industries, thereby supporting market growth.
For instance, according to the 2024 updated data from the Canadian Cancer Society, the number of cancer cases in Canada ramped from 239,100 in 2023 to 247,100 in 2024. This notable rise in the burden of chronic diseases is poised to bolster regional market growth over the coming years.
Moreover, the substantial biopharmaceutical sector in the region, coupled with growing demand for biopharmaceuticals, is further projected to boost the regional market growth over the coming years. For instance, according to a 2024 report published by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the research and development expenditure of the United States biopharmaceutical sector was 71,459 million in 2023, compared to 14,187 in China and 47,010 in Europe.
This notable R&D of the biopharmaceutical sector will likely fuel the adoption of single-use pumps across biopharmaceutical sectors for different liquid handling operations, thereby fueling industry growth.
Furthermore, the availability of technologically advanced platforms and several initiatives undertaken by the key market participants are poised to foster regional market growth over the coming years. For instance, in December 2024, Finish Thompson Inc. showcased its MSDB centrifugal pump series, specifically designed for pharmaceutical applications in the United States. The highlighted product delivers reliable flow performance and ensures precise operational efficiency. Such initiatives undertaken by the key market participants are likely to expand industry growth over the coming years.
Hence, the factors mentioned above, including expanding the biopharmaceutical sector in the region coupled with the growing availability of technologically advanced pumps, are projected to foster regional market expansion over the coming years.
Get Analysis on Important Geographic Markets
Download PDF
Single-Use Pump Industry Overview
The single-use pump market is competitive due to the presence of several global companies and is semi-consolidated in nature. The market comprises international companies that hold significant market shares and have established brand recognition. Companies in the single-use pump market pursue organic and inorganic initiatives to strengthen their business operations. Some of the key players operating in the market include ESI Ultrapure, Interscience, Levitronix, Watson-Marlow Fluid Technology Solutions, and Xylem, among others.
Single-Use Pump Market Leaders
-
Fluid Flow Products, Inc.
-
Levitronix
-
SMC Corporation
-
Watson-Marlow Fluid Technology Solutions
-
Xylem
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Single-Use Pump Market News
- July 2024: Watson-Marlow Fluid Technology Group (WMFTG) launched a range of new products, including an advanced bioprocessing pump featuring single-use technology. This pump was designed to enhance downstream process performance, delivering higher yields and improved flow within a 44 Psi pressure range, while also offering ultra-low shear and performance.
- April 2024: Xylem introduced the Jabsco PureFlo 21 single-use pump, marking a significant advancement for the pharmaceutical and biotechnology sectors. This innovative pump incorporated an adjustable, integrated pressure relief valve, a first in single-use pumping technology, designed to reduce the risk of fluid contamination while enhancing operator safety.
Single-Use Pump Industry Segmentation
As per the scope of the report, single-use pumps are specialized pumping systems designed for one-time use, primarily in biopharmaceutical manufacturing processes. They ensure contamination-free product handling and compliance with strict regulatory standards, enhancing operational efficiency and safety.
The single-use pump market is segmented by product, flow rate, end-use, and geography. By product, the market is segmented as equipment and accessories. By flow rate, the market is segmented as high flow and low flow. By end-use, the market is segmented as biopharmaceutical & pharmaceutical companies, CROs & CMOs, and others. The report also covers the market sizes and forecasts for the single-use pumps market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Product | Equipment | Peristaltic pumps | |
| Quaternary Diaphragm Pump | |||
| Centrifugal Pumps | |||
| Others | |||
| Accessories | |||
| By Flow Rate | High Flow | ||
| Low Flow | |||
| By End-Use | Biopharmaceutical & Pharmaceutical Companies | ||
| CROs & CMOs | |||
| Others | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Single-Use Pump Market Research FAQs
How big is the Single-Use Pump Market?
The Single-Use Pump Market size is expected to reach USD 0.63 billion in 2025 and grow at a CAGR of 14.75% to reach USD 1.25 billion by 2030.
What is the current Single-Use Pump Market size?
In 2025, the Single-Use Pump Market size is expected to reach USD 0.63 billion.
Who are the key players in Single-Use Pump Market?
Fluid Flow Products, Inc., Levitronix, SMC Corporation, Watson-Marlow Fluid Technology Solutions and Xylem are the major companies operating in the Single-Use Pump Market.
Which is the fastest growing region in Single-Use Pump Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Single-Use Pump Market?
In 2025, the North America accounts for the largest market share in Single-Use Pump Market.
What years does this Single-Use Pump Market cover, and what was the market size in 2024?
In 2024, the Single-Use Pump Market size was estimated at USD 0.54 billion. The report covers the Single-Use Pump Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Single-Use Pump Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
